Cardiogen 20mg
Cardiogen is an advanced bioregulator peptide recognized for its remarkable therapeutic potential across multiple physiological systems, particularly cardiovascular health, prostate function, and cellular regeneration. This cutting-edge research compound demonstrates significant promise in addressing heart conditions, chronic diseases, and age-related cellular dysfunction through its unique mechanism of action on fibroblast regulation.
Product Specifications
Molecular Formula: C₁₈H₃₁N₇O₉
Molecular Weight: 489.5 g/mol
Purity: ≥98% (HPLC verified)
Form: Lyophilized powder
Storage: Store at -20°C, protect from light
Stability: 24 months when stored properly
 
Mechanism of Action & Research Applications
Cardiogen functions as a sophisticated bioregulator, primarily targeting fibroblast activity throughout the body. Fibroblasts play crucial roles in tissue repair, scar formation, and cellular regeneration processes. Research indicates that Cardiogen's regulatory effects extend far beyond its namesake cardiovascular applications, demonstrating therapeutic potential in multiple organ systems.
Cardiovascular Research Applications
Heart Muscle Protection & Regeneration
Cardiogen exhibits remarkable cardioprotective properties through multiple pathways:
Cardiomyocyte Proliferation: Stimulates the growth and regeneration of heart muscle cells
Fibrosis Reduction: Minimizes excessive scar tissue formation following cardiac events
Cardiac Remodeling: Prevents pathological changes that lead to heart failure
Apoptosis Regulation: Reduces programmed cell death in cardiac tissue by modulating p53 protein expression
Clinical Research Applications:
Post-myocardial infarction recovery
Hypertension management
Chronic heart failure treatment
Cardiovascular aging intervention
 
Oncological Research Potential
Emerging research reveals Cardiogen's dual-action profile in cancer research:
Selective Tumor Cell Targeting
Unlike its protective effects in healthy tissue, Cardiogen demonstrates pro-apoptotic activity in malignant cells:
Sarcoma Research: Dose-dependent increase in tumor cell death in M-1 sarcoma models
Selective Action: Enhanced targeting of tumor cells due to their abnormal vascular architecture
Combination Therapy: Potential synergistic effects with established cancer treatments
Research from the St. Petersburg Institute of Bioregulation and Gerontology positions Cardiogen as a promising candidate for sarcoma treatment protocols.
Prostate Health & Age-Related Changes
Cellular Microenvironment Optimization
Cardiogen demonstrates significant effects on prostate tissue homeostasis:
Fibroblast Signaling: Normalizes expression of critical signaling factors in prostate fibroblasts
Age Reversal Properties: Restores cellular markers to youthful levels in senescent cells
Cancer Prevention: May prevent development and progression of prostate malignancies
Hormonal Balance: Supports healthy prostate function through cellular regulation
Synergistic Treatment Enhancement
One of Cardiogen's most significant advantages is its ability to enhance the effectiveness of conventional treatments while potentially reducing side effects. This synergistic action has been documented in:
Cardiovascular disease management
Cancer treatment protocols
Age-related cellular dysfunction
Research Dosage & Administration
Standard Research Protocol:
Typical research dosage: 20mg per administration
Route: Subcutaneous injection (preferred) or oral administration
Frequency: As per research protocol requirements
Duration: Protocol-dependent (typically 4-12 weeks)
Bioavailability Profile:
Excellent subcutaneous absorption
Good oral bioavailability
Minimal systemic side effects
Rapid tissue distribution
Safety Profile & Contraindications
Cardiogen demonstrates an excellent safety profile in research applications:
Favorable Characteristics:
Minimal adverse effects reported
No significant drug interactions identified
Well-tolerated across various research models
Low toxicity profile
 
Research Applications & Future Directions
Current Research Focus:
Cardiovascular disease intervention
Cancer treatment enhancement
Anti-aging cellular therapy
Regenerative medicine applications
Emerging Applications:
Tissue engineering support
Wound healing acceleration
Neuroprotective research
Metabolic disorder investigation
Important Research Disclaimers
FOR RESEARCH USE ONLY
This product is intended solely for in-vitro research and educational purposes. Cardiogen has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. This product is not for human consumption or clinical use.
Research Compliance:
Licensed researchers only
Institutional review required
Proper laboratory facilities necessary
Documentation of research protocols mandatory
Storage & Handling Instructions
Powder Form:
Store at -20°C (-4°F)
Protect from light and moisture
Use desiccant packets
Avoid repeated freeze-thaw cycles
 
References & Scientific Background
Research on Cardiogen is based on decades of peptide bioregulator studies pioneered by leading researchers in gerontology and peptide therapy. The compound's development represents years of investigation into cellular regulation mechanisms and age-related physiological changes.
 
Order Information:
Product Code: CRG-20MG
Package Size: 20mg vial
Minimum Order: 1 vial
PeptidesAlpha is committed to providing the highest quality research peptides for advancing scientific discovery and medical research.